Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Capital Expenditures (2016 - 2021)

Cavitation Technologies' Capital Expenditures history spans 9 years, with the latest figure at $250000.0 for Q3 2021.

  • For Q3 2021, Capital Expenditures rose 233.33% year-over-year to $250000.0; the TTM value through Sep 2022 reached $253000.0, down 16.5%, while the annual FY2021 figure was $128000.0, 156.0% up from the prior year.
  • Capital Expenditures for Q3 2021 was $250000.0 at Cavitation Technologies, up from $3000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $250000.0 in Q3 2021 and bottomed at $1000.0 in Q2 2019.
  • The 3-year median for Capital Expenditures is $50000.0 (2020), against an average of $71500.0.
  • The largest annual shift saw Capital Expenditures surged 4900.0% in 2020 before it tumbled 94.0% in 2021.
  • A 3-year view of Capital Expenditures shows it stood at $1000.0 in 2019, then soared by 4900.0% to $50000.0 in 2020, then surged by 400.0% to $250000.0 in 2021.
  • Per Business Quant, the three most recent readings for CVAT's Capital Expenditures are $250000.0 (Q3 2021), $3000.0 (Q2 2021), and $50000.0 (Q4 2020).